EUVIMEDEUVIMED entdecken
Crossref

Psychotropic Polypharmacy as a Marker of Procedural Utilization in Multidisciplinary PM&R Pain Management

Jocelyn Kim, John A. Villanueva, Emily Hoang, Kalie Quon‐Adams

PM&R · 2026-11 · 18 (S3)

DOI: 10.1002/pmrj.220_70259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Jocelyn Kim und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Setting

Literature based review of clinical practice guidelines and peer-reviewed studies.

Participants

Not applicable.

Interventions

Not applicable.Main Outcome Measures: Development of a clinically applicable framework integrating platelet count, coagulation parameters, anticoagulation status, and neutropenia with procedural bleeding and infection risk. Results:Pre-procedural assessment is best approached through a unified framework integrating procedural invasiveness with patient-specific hematologic risk.Procedures are categorized as low, intermediate, or high risk.All reviewed guidelines recommend a platelet count of at least 50 Â 10 9 /L for elective procedures, up to 70 Â 10 9 /L for high-risk procedures.Anticoagulation management remains dependent on the procedural category; INR values greater than 1.5 are often considered too high for high-risk procedures.Infection risk is incorporated using oncology hematology literature, with severe neutropenia (absolute neutrophil count < 500 cells/μL) identifying patients at highest risk.

Conclusions

Pre-procedural laboratory assessment requires integration of procedural bleeding risk with patient-specific hematologic factors.This review provides a practical, risk-stratified framework incorporating platelet count, coagulation parameters, anticoagulation status, and neutropenia to guide clinical decisionmaking.Further research is needed to establish oncology-specific thresholds and optimize procedural safety.

Zitieren

APA

Kim, J., Villanueva, J. A., Hoang, E., & Quon‐Adams, K. (2026). Psychotropic Polypharmacy as a Marker of Procedural Utilization in Multidisciplinary PM&R Pain Management. PM&R, 18(S3). https://doi.org/10.1002/pmrj.220_70259

Vancouver

Kim J, Villanueva JA, Hoang E, Quon‐Adams K. Psychotropic Polypharmacy as a Marker of Procedural Utilization in Multidisciplinary PM&R Pain Management. PM&R. 2026;18(S3). doi:10.1002/pmrj.220_70259

BibTeX
@article{Kim2026,
  author = {Kim, Jocelyn and Villanueva, John A. and Hoang, Emily and Quon‐Adams, Kalie},
  title = {Psychotropic Polypharmacy as a Marker of Procedural Utilization in Multidisciplinary PM&R Pain Management},
  journal = {PM&R},
  year = {2026},
  volume = {18},
  number = {S3},
  doi = {10.1002/pmrj.220_70259}
}
Kostenlos starten →